FDA Issues Recall for Blood Pressure Medication Over Efficacy Concerns

The FDA has initiated a Class II recall for over 11,000 bottles of chlorthalidone (25mg tablets), a blood pressure medication, due to issues with dissolution specifications. This failure could compromise the drug's effectiveness, potentially affecting patient health. Patients are advised to consult their healthcare provider before discontinuing the medication.